James McDermott

867 total citations · 1 hit paper
19 papers, 469 citations indexed

About

James McDermott is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James McDermott has authored 19 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James McDermott's work include Heart Failure Treatment and Management (11 papers), Diabetes Treatment and Management (6 papers) and Medication Adherence and Compliance (3 papers). James McDermott is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Diabetes Treatment and Management (6 papers) and Medication Adherence and Compliance (3 papers). James McDermott collaborates with scholars based in United States, United Kingdom and Ireland. James McDermott's co-authors include Joanna Huang, Scott D. Solomon, Adam D. DeVore, Clyde W. Yancy, Anjali Owens, Gregg C. Fonarow, Paul A. Heidenreich, M. Kittleson, Pamela N. Peterson and Orly Vardeny and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and European Heart Journal.

In The Last Decade

James McDermott

18 papers receiving 458 citations

Hit Papers

Electronic Alerts to Improve Heart Failure Therapy in Out... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James McDermott United States 10 287 148 136 46 43 19 469
Wing Chan United States 14 303 1.1× 70 0.5× 44 0.3× 59 1.3× 80 1.9× 25 620
Anne S. Hellkamp United States 15 556 1.9× 89 0.6× 41 0.3× 19 0.4× 37 0.9× 24 678
Anthony Carnicelli United States 15 494 1.7× 85 0.6× 59 0.4× 32 0.7× 192 4.5× 69 809
John K. Cuddeback United States 10 108 0.4× 87 0.6× 199 1.5× 17 0.4× 105 2.4× 23 446
Lorraine Kearney United Kingdom 10 324 1.1× 46 0.3× 105 0.8× 12 0.3× 64 1.5× 13 548
Michael Urbich Switzerland 6 224 0.8× 32 0.2× 37 0.3× 20 0.4× 60 1.4× 10 348
Tonje Thorvaldsen Sweden 12 363 1.3× 80 0.5× 87 0.6× 20 0.4× 61 1.4× 23 432
Tobias Täger Germany 14 328 1.1× 73 0.5× 102 0.8× 12 0.3× 66 1.5× 35 484
Alicia Uijl Netherlands 13 597 2.1× 55 0.4× 103 0.8× 19 0.4× 80 1.9× 32 714
Ruri Abe Japan 14 543 1.9× 76 0.5× 52 0.4× 7 0.2× 75 1.7× 28 662

Countries citing papers authored by James McDermott

Since Specialization
Citations

This map shows the geographic impact of James McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McDermott more than expected).

Fields of papers citing papers by James McDermott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McDermott. The network helps show where James McDermott may publish in the future.

Co-authorship network of co-authors of James McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of James McDermott. A scholar is included among the top collaborators of James McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James McDermott. James McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kittipibul, Veraprapas, Muthiah Vaduganathan, Karen Chiswell, et al.. (2024). Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy. JACC Heart Failure. 12(8). 1409–1421. 3 indexed citations
2.
Ostrominski, John W., Stephen J. Greene, Ravi B. Patel, et al.. (2024). Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure. JAMA Cardiology. 9(7). 667–667. 1 indexed citations
3.
Bhatt, Ankeet S., Gregg C. Fonarow, Stephen J. Greene, et al.. (2023). Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines – Heart Failure Registry. Journal of Cardiac Failure. 30(2). 319–328. 7 indexed citations
5.
Pierce, Jacob B., Muthiah Vaduganathan, Gregg C. Fonarow, et al.. (2023). Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US. JAMA Cardiology. 8(7). 652–652. 56 indexed citations
6.
Ghazi, Lama, Yu Yamamoto, Michael Fuery, et al.. (2023). Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial. European Heart Journal. 44(40). 4233–4242. 21 indexed citations
7.
Ghazi, Lama, Yu Yamamoto, Ralph J. Riello, et al.. (2022). Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice. Journal of the American College of Cardiology. 79(22). 2203–2213. 109 indexed citations breakdown →
8.
Ghazi, Lama, Yu Yamamoto, Michael Fuery, et al.. (2022). Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial. American Heart Journal. 257. 111–119. 3 indexed citations
9.
Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, et al.. (2021). Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure. Journal of Cardiac Failure. 28(4). 554–563. 8 indexed citations
10.
Patel, Ravi B., Gregg C. Fonarow, Stephen J. Greene, et al.. (2021). Kidney Function and Outcomes in Patients Hospitalized With Heart Failure. Journal of the American College of Cardiology. 78(4). 330–343. 106 indexed citations
12.
Stuart, Richard B., et al.. (2021). Use of conditional medical orders to minimize moral, ethical, and legal risk in critical care. Journal of Healthcare Risk Management. 41(3). 14–23. 2 indexed citations
13.
Vaduganathan, Muthiah, Stephen J. Greene, Shuaiqi Zhang, et al.. (2020). Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice. JAMA Cardiology. 6(3). 267–267. 31 indexed citations
14.
McDermott, James, et al.. (2008). Early Radical Surgery and Antimicrobial Therapy with Hyperbaric Oxygen in Necrotizing Fasciitis. Plastic & Reconstructive Surgery. 121(1). 360–361. 5 indexed citations
15.
Sautoy, M. P. F. Du, James McDermott, & Geoff C. Smith. (1999). Zeta Functions of Crystallographic Groups and Analytic Continuation. Proceedings of the London Mathematical Society. 79(3). 511–534. 12 indexed citations
16.
McDermott, James. (1995). The first step.. PubMed. 273(3). 251–3. 1 indexed citations
17.
Dutka, A J, Richard Mink, James McDermott, J. B. Clark, & John M. Hallenbeck. (1992). Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism.. Stroke. 23(10). 1515–1520. 37 indexed citations
18.
McDermott, James, A J Dutka, Delbert E. Evans, & E. T. Flynn. (1990). Treatment of experimental cerebral air embolism with lidocaine and hyperbaric oxygen.. PubMed. 17(6). 525–34. 19 indexed citations
19.
Evans, Delbert E., et al.. (1989). Effect of lidocaine after experimental cerebral ischemia induced by air embolism. Journal of neurosurgery. 70(1). 97–102. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026